Ventricular and Lumbar Cerebrospinal Fluid Concentrations of Alzheimer's Disease Biomarkers in Patients with Normal Pressure Hydrocephalus and Posttraumatic Hydrocephalus
Sebastian Brandner(Universitätsklinikum Erlangen), Piotr Lewczuk(Universitätsklinikum Erlangen), Michael Buchfelder(Friedrich-Alexander-Universität Erlangen-Nürnberg), Andrea Kleindienst(Friedrich-Alexander-Universität Erlangen-Nürnberg), Christian Thaler(Universität Hamburg), Johannes Kornhuber(Friedrich-Alexander-Universität Erlangen-Nürnberg), Juan Manuel Maler(Friedrich-Alexander-Universität Erlangen-Nürnberg), Natalia Lelental(Friedrich-Alexander-Universität Erlangen-Nürnberg)
Cited by 41
Related Papers
A Practical Guide to Immunoassay Method Validation
|Frontiers in Neurology|2015|541
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
|Alzheimer s & Dementia|2011|412
CSF biomarker variability in the Alzheimer's Association quality control program
|Alzheimer s & Dementia|2013|386
Consensus on diagnosis and management of Cushing's disease: a guideline update
|White Rose Research Online (University of Leeds, The University of Sheffield, University of York)|2021|351
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia
|JAMA Psychiatry|2017|148